The North America cold chain market is poised for growth fueled by increasing demand for temperature-sensitive ...

GLP-1 Drugs Distribution · GlobeNewswire Inc. Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "GLP-1 Market: Industry Trends and Global Forecasts, Till 2035" report has been added to ...

In Malawi's public hospitals, a quiet but devastating crisis is unfolding. Patients are increasingly being forced to buy medicines that are supposed to be free, as chronic drug shortages continue to ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 4 includes Eli Lilly, Enterprise Products ...

Audien Hearing Aids 2026 explores how the Audien Atom Hearing Aid delivers FDA-compliant OTC hearing care, advanced design, ...

REZENOPY™ received approval from the U.S. Food and Drug Administration (the "FDA”) on April 19, 2024. The newly issued patent is eligible for listing in the FDA’s Orange Book and, if listed, may ...

Good enough, the answer is right here before us as he is none other than Dr. Lucky Orimisan Aiyedatiwa (born 12 January 1965) ...

Discover how to identify and invest in the best growth stocks for long-term wealth building. Learn key characteristics, sectors to watch and strategies for building a robust growth portfolio.

Specialty pharmaceuticals are typically high-cost therapies used to treat chronic, complex, or rare diseases. These products ...

OPERATION HAS TIES TO A MEXICAN CARTEL. WE WILL GO ANYWHERE IN THE STATE TO TARGET THOSE INDIVIDUALS THAT ARE PUSHING POISON IN OUR COMMUNITIES. THE DEA AND FRANKLIN POLICE DEPARTMENT WORKED TOGETHER ...

Two studies led by an opioid treatment program run by the University at Buffalo and UBMD Emergency Medicine have found that ...

Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...